Table 1.
Group | Survival | Disease-free survival | |||||
---|---|---|---|---|---|---|---|
N | 10-Year | 95% CI | p Value | 10-Year | 95% CI | p Value | |
All patients | 53 | 81.9% | 68.0, 90.2 | — | 78.5% | 64.5, 87.5 | — |
Tumor size | 0.37 | 0.28 | |||||
≤ 10 | 36 | 85.7% | 68.9, 93.8 | 83.1% | 66.2, 92.1 | ||
> 10 | 17 | 74.7% | 45.5, 89.7 | 69.1% | 40.7, 85.9 | ||
Age | 0.048 | 0.16 | |||||
18–30 years | 29 | 92.5% | 85.2% | ||||
31–77 years | 24 | 70.6% | 70.6% | ||||
Histologic response | 0.08 | 0.035 | |||||
Poor (≤ 90) | 12 | 64.8% | 31.0, 85.2 | 56.3% | 24.4, 79.1 | ||
Good (> 90) | 41 | 87.3% | 72.2, 94.5 | 85.1% | 69.9, 93.0 |